Home > News > Biophan CEO Addresses NanoBio Convergence Conference
October 27th, 2005
Biophan CEO Addresses NanoBio Convergence Conference
Abstract:
Biophan Technologies, Inc., a developer of next-generation medical technology, presented its proprietary nanotech-based solutions for drug delivery, vascular intervention and other global biomedical market segments at the NanoBioConvergence conference held yesterday in the San Francisco Bay Area.
Source:
businesswire
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Energy
KAIST researchers introduce new and improved, next-generation perovskite solar cell November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Groundbreaking precision in single-molecule optoelectronics August 16th, 2024
Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||